Investigation for Investors of Esperion Therapeutics Inc (NASDAQ:ESPR) Announced
Certain directors of Esperion Therapeutics Inc are under investigation over possible misconduct. The investigation was announced for investors in NASDAQ:ESPR shares concerning potential breaches of fiduciary duties by certain Esperion Therapeutics directors.
View full press release